Masitinib mesylate
Masitinib mesylate is an orally active, selective tyrosine kinase inhibitor targeting c-Kit, PDGFRα/β, and Lyn. It is widely used in preclinical research for investigating mast cell disorders, cancers, and inflammatory diseases, with applications in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1048007-93-7
Product Name Alternative
Apoptosis, AB-1010, AB1010 Mesylate, AB-1010 mesylate, AB-1010 Mesylate, AB1010, AB 1010, AB 1010 Mesylate, c-Kit, cKit, CD117, Platelet-derived growth factor receptor, Lyn, Kit, inhibit, Fibroblast growth factor receptor, FGFR3, FGFR, FAK, Masitinib, Masitinib mesylate, Masitinib Mesylate, LCK, Inhibitor, PDGFRβ, PDGFRα, PDGFR, Src, SCFR
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Purity
97.67% (May vary between batches)
Solubility
DMSO:50 mg/mL (84.07 mM)
Smiles
CS (O) (=O) =O.CN1CCN (Cc2ccc (cc2) C (=O) Nc2ccc (C) c (Nc3nc (cs3) -c3cccnc3) c2) CC1
Molecular Formula
C29H34N6O4S2
Molecular Weight
594.75
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
rAP-2098 1 Each
Ubiquitin-Conjugating Enzyme E2, J2 Human Recombinant
Sign In for Pricing
View Details 
042197-HRP 200 µL
SPAK, ID (STK39, SPAK, STE20/SPS1-related proline-alanine-rich protein kinase, DCHT, Serine/threonine-protein kinase 39) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details